Epilepszia: vizsgálatok itt: Hollandia
14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleOV329 Evaluation in Participants with Epilepsy and PPR
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 4
- Run by
- Ovid Therapeutics Inc.
See details and how to join2026-527114-23-00 · EU 2026-527114-23-00 - 3. fázisTaking peopleA Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Where
- Heeze
- Életkor
- 12 év and over
- People
- 160 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00 - 3. fázisTaking peopleA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Where
- Heeze
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00 - 3. fázisCsak meghívásosAn Open-label Study of XEN1101 in Epilepsy
- Where
- Heeze
- Életkor
- 12 év and over
- People
- 880 worldwide
- Run by
- Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00 - No phaseTaking peopleMulti-biomarkers in DEE
- Where
- Amsterdam
- Életkor
- 0 év to 55 év
- People
- 200 worldwide
- Run by
- Istituto Giannina Gaslini
See details and how to joinNCT07909382 - 3. fázisCsak meghívásosA Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
- Where
- Utrecht
- Életkor
- 2 év to 66 év
- People
- 324 worldwide
- Run by
- Longboard Pharmaceuticals
See details and how to joinNCT06908226 · EU 2024-514974-39-00 - No phaseTaking peopleProspective Natural History Study of POLG Disease
- Where
- Maastricht
- People
- 300 worldwide
- Run by
- The POLG Foundation
See details and how to joinNCT07775872 - 1. fázisTaking peopleThree-part PK and PD study of AXN-027
- Where
- Leiden
- Életkor
- 18 év to 64 év
- People
- 64
- Run by
- Axonis Therapeutics Inc.
See details and how to join2025-524019-35-00 · EU 2025-524019-35-00 - 2. fázisNot yet taking people in HollandiaA Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Potential Antiseizure Activity of Adjunctive OV329 Therapy in Adults with Drug-Resistant Focal Epilepsy
- Where
- Maastricht
- Életkor
- 18 év and over
- People
- 6
- Run by
- Ovid Therapeutics Inc.
See details and how to join2026-525896-23-00 · EU 2026-525896-23-00 - 3. fázisTaking peopleCannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
- Where
- Utrecht
- Életkor
- 1 év to 18 év
- People
- 50
- Run by
- UMC Utrecht
See details and how to joinNCT07668856 - 2. fázisCsak meghívásosLong-term Safety and Tolerability of BHV-7000
- Where
- Heemstede, Heeze, Zwolle
- Életkor
- 18 év to 75 év
- People
- 660 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00 - 3. fázisTaking peopleCannabidiol in refractory childhood epilepsy, a personalized high-quality approach
- Where
- Heemstede, Heeze, Maastricht, Rotterdam, Utrecht
- Életkor
- Up to 17 év
- People
- 50
- Run by
- Universitair Medisch Centrum Utrecht
See details and how to join2023-507843-12-01 · EU 2023-507843-12-01 - No phaseTaking peopleEvaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid )
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 12
- Run by
- Neurosoft Bioelectronics SA
See details and how to joinNCT06205160 - No phaseTaking peopleREACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
- Where
- Heeze
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Aziende Chimiche Riunite Angelini Francesco S.p.A
See details and how to joinNCT06922175